搜尋





搜尋





市場行情
/
股票
/
krys
/

Krystal Biotech Inc

KRYS

添加自選

352.060USD

+16.870+5.03%

收盤 07-27 16:00（美東）報價延遲15分鐘

10.28B總市值

45.45本益比TTM

Krystal Biotech Inc

352.060

+16.870+5.03%

概覽

財務

分析

公司

財務摘要利潤表資產負債表現金流量表

KRYS 利潤表

您可以在這裡找到Krystal Biotech Inc的年度或季度收入報告，以深入了解Krystal Biotech Inc的營運、管理效率和表現。

單季報

單季報+年報

單季報

年報

YOY

隱藏空白列

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q4

FY2019Q3

FY2019Q2

FY2019Q1

FY2018Q4

FY2018Q3

FY2018Q2

FY2018Q1

FY2017Q4

FY2017Q3

FY2017Q2

FY2017Q1

FY2016Q4

FY2016Q3

FY2016Q2

FY2016Q1

營業總收入

31.95%116.36M

17.52%107.11M

16.65%97.80M

36.65%96.04M

94.88%88.18M

116.26%91.14M

879.91%83.84M

--70.28M

--45.25M

--42.14M

--8.56M

----

--0.00

----

--0.00

營業收入

31.95%116.36M

17.52%107.11M

16.65%97.80M

36.65%96.04M

94.88%88.18M

116.26%91.14M

879.91%83.84M

--70.28M

--45.25M

--42.14M

--8.56M

----

--0.00

----

--0.00

主營業務成本

25.76%6.32M

33.20%6.59M

-36.22%4.26M

19.24%7.17M

107.85%5.03M

72.38%4.95M

2897.31%6.68M

--6.01M

--2.42M

--2.87M

--223.00K

----

營業費用

20.50%62.67M

26.28%62.84M

15.37%56.43M

15.27%56.73M

31.88%52.01M

27.57%49.76M

41.56%48.91M

29.36%49.22M

8.56%39.43M

12.18%39.01M

9.85%34.55M

32.33%38.05M

44.01%36.32M

58.95%34.77M

100.94%31.45M

75.40%28.75M

75.73%25.22M

109.94%21.88M

61.69%15.65M

135.73%16.39M

141.39%14.35M

69.32%10.42M

81.21%9.68M

18.06%6.95M

26.67%5.95M

45.86%6.15M

79.74%5.34M

140.51%5.89M

106.15%4.69M

181.64%4.22M

42.00%2.97M

242.52%2.45M

389.68%2.28M

141.61%1.50M

550.00%2.09M

255.72%715.00K

--465.00K

--620.00K

--322.00K

--201.00K

--0.00

研發費用

7.55%15.33M

9.40%14.79M

7.95%14.59M

-7.53%14.41M

30.10%14.26M

18.94%13.52M

27.11%13.51M

28.32%15.58M

-10.83%10.96M

5.86%11.37M

-7.70%10.63M

11.52%12.14M

31.93%12.29M

19.23%10.74M

89.41%11.52M

65.15%10.89M

50.20%9.31M

58.83%9.01M

19.22%6.08M

81.20%6.59M

75.91%6.20M

30.42%5.67M

31.27%5.10M

-13.69%3.64M

11.30%3.52M

55.21%4.35M

102.98%3.88M

176.46%4.22M

108.36%3.17M

157.54%2.80M

41.25%1.91M

241.93%1.52M

376.49%1.52M

170.65%1.09M

462.24%1.35M

355.10%446.00K

--319.00K

--402.00K

--241.00K

--98.00K

--0.00

折舊攤銷及損耗

-6.85%1.52M

0.45%1.56M

-8.24%1.40M

-33.25%1.35M

1.55%1.63M

-36.22%1.56M

27.42%1.53M

68.42%2.02M

46.27%1.61M

123.88%2.44M

23.08%1.20M

22.95%1.20M

8.37%1.10M

38.90%1.09M

24.52%975.00K

46.55%976.00K

89.37%1.01M

60.00%784.00K

64.15%783.00K

21.31%666.00K

60.00%536.00K

96.00%490.00K

149.74%477.00K

213.71%549.00K

153.79%335.00K

309.84%250.00K

402.63%191.00K

629.17%175.00K

633.33%132.00K

335.71%61.00K

660.00%38.00K

700.00%24.00K

1700.00%18.00K

1300.00%14.00K

--5.00K

200.00%3.00K

--1.00K

--0.00

--1.00K

--0.00

營業利潤

48.41%53.69M

6.99%44.27M

18.44%41.37M

86.59%39.31M

522.03%36.18M

1218.64%41.38M

234.39%34.93M

155.37%21.07M

116.01%5.82M

109.02%3.14M

17.35%-25.99M

-32.33%-38.05M

-44.01%-36.32M

-58.95%-34.77M

-100.94%-31.45M

-75.40%-28.75M

-75.73%-25.22M

-109.94%-21.88M

-61.69%-15.65M

-135.73%-16.39M

-141.39%-14.35M

-69.32%-10.42M

-81.21%-9.68M

-18.06%-6.95M

-26.67%-5.95M

-45.86%-6.15M

-79.74%-5.34M

-140.51%-5.89M

-106.15%-4.69M

-181.64%-4.22M

-42.00%-2.97M

-242.52%-2.45M

-389.68%-2.28M

-141.61%-1.50M

-550.00%-2.09M

-255.72%-715.00K

---465.00K

---620.00K

---322.00K

---201.00K

--0.00

淨非營業利息收入（費用）

利息收入

----

3784.29%2.72M

2441.27%1.60M

2050.00%645.00K

678.79%257.00K

--70.00K

--63.00K

--30.00K

--33.00K

----

利息費用

----

--0.00

-100.00%0.00

--0.00

--1.49M

----

特殊收入（費用）

----

--0.00

100.00%0.00

--0.00

-112.50%-12.50M

---12.50M

0.00%-12.50M

--0.00

--100.00M

--0.00

50.00%-12.50M

--0.00

---25.00M

----

稅前利潤

40.93%61.44M

5.19%51.13M

61.13%47.97M

191.52%46.77M

4577.79%43.60M

356.13%48.61M

-63.13%29.77M

148.31%16.05M

102.06%932.00K

133.25%10.66M

370.51%80.75M

-18.15%-33.21M

9.34%-45.30M

-46.99%-32.05M

-91.48%-29.85M

-71.78%-28.11M

-215.99%-49.97M

-110.02%-21.81M

-62.22%-15.59M

-139.47%-16.36M

-196.05%-15.81M

-93.82%-10.38M

-124.95%-9.61M

-27.77%-6.83M

-29.92%-5.34M

-44.47%-5.36M

-55.06%-4.27M

-134.97%-5.35M

-91.21%-4.11M

-166.19%-3.71M

47.75%-2.75M

-199.87%-2.28M

-335.22%-2.15M

-122.17%-1.39M

-1537.58%-5.27M

-277.61%-759.00K

---494.00K

---627.00K

---322.00K

---201.00K

--0.00

所得稅

-29.93%5.51M

-108.59%-269.00K

-1312.75%-31.40M

1669.81%8.44M

--7.86M

59.34%3.13M

--2.59M

--477.00K

----

--1.96M

----

--0.00

----

--0.00

----

--0.00

除稅後利潤

56.53%55.93M

13.02%51.40M

192.00%79.36M

146.23%38.33M

3734.01%35.73M

423.23%45.48M

-66.34%27.18M

146.88%15.57M

102.06%932.00K

127.12%8.69M

370.51%80.75M

-18.15%-33.21M

9.34%-45.30M

-46.99%-32.05M

-91.48%-29.85M

-71.78%-28.11M

-215.99%-49.97M

-110.02%-21.81M

-62.22%-15.59M

-139.47%-16.36M

-196.05%-15.81M

-93.82%-10.38M

-124.95%-9.61M

-27.77%-6.83M

-29.92%-5.34M

-44.47%-5.36M

-55.06%-4.27M

-134.97%-5.35M

-91.21%-4.11M

-166.19%-3.71M

47.75%-2.75M

-199.87%-2.28M

-335.22%-2.15M

-122.17%-1.39M

-1537.58%-5.27M

-277.61%-759.00K

---494.00K

---627.00K

---322.00K

---201.00K

--0.00

持續經營利潤

56.53%55.93M

13.02%51.40M

192.00%79.36M

146.23%38.33M

3734.01%35.73M

423.23%45.48M

-66.34%27.18M

146.88%15.57M

102.06%932.00K

127.12%8.69M

370.51%80.75M

-18.15%-33.21M

9.34%-45.30M

-46.99%-32.05M

-91.48%-29.85M

-71.78%-28.11M

-215.99%-49.97M

-110.02%-21.81M

-62.22%-15.59M

-139.47%-16.36M

-196.05%-15.81M

-93.82%-10.38M

-124.95%-9.61M

-27.77%-6.83M

-29.92%-5.34M

-44.55%-5.36M

-55.06%-4.27M

-134.97%-5.35M

-91.21%-4.11M

-166.04%-3.71M

47.75%-2.75M

-199.87%-2.28M

-335.22%-2.15M

-122.17%-1.39M

-1537.58%-5.27M

-277.61%-759.00K

---494.00K

---627.00K

---322.00K

---201.00K

--0.00

反常淨利潤

----

--0.00

----

--0.00

----

其他淨損益

----

--2.00K

----

歸属于母公司的淨利潤

56.53%55.93M

13.02%51.40M

192.00%79.36M

146.23%38.33M

3734.01%35.73M

423.23%45.48M

-66.34%27.18M

146.88%15.57M

102.06%932.00K

127.12%8.69M

370.51%80.75M

-18.15%-33.21M

9.34%-45.30M

-46.99%-32.05M

-91.48%-29.85M

-71.78%-28.11M

-215.99%-49.97M

-110.02%-21.81M

-62.22%-15.59M

-139.47%-16.36M

-196.05%-15.81M

-93.82%-10.38M

-124.95%-9.61M

-27.77%-6.83M

-29.92%-5.34M

-44.47%-5.36M

-55.06%-4.27M

-134.97%-5.35M

-91.21%-4.11M

-166.19%-3.71M

47.75%-2.75M

-199.87%-2.28M

-335.22%-2.15M

-122.17%-1.39M

-1537.58%-5.27M

-277.61%-759.00K

---494.00K

---627.00K

---322.00K

---201.00K

--0.00

歸屬普通股東的淨利潤

56.53%55.93M

13.02%51.40M

192.00%79.36M

146.23%38.33M

3734.01%35.73M

423.23%45.48M

-66.34%27.18M

146.88%15.57M

102.06%932.00K

127.12%8.69M

370.51%80.75M

-18.15%-33.21M

9.34%-45.30M

-46.99%-32.05M

-91.48%-29.85M

-71.78%-28.11M

-215.99%-49.97M

-110.02%-21.81M

-62.22%-15.59M

-139.47%-16.36M

-196.05%-15.81M

-93.82%-10.38M

-124.95%-9.61M

-27.77%-6.83M

-29.92%-5.34M

-44.47%-5.36M

-55.06%-4.27M

-134.97%-5.35M

-91.21%-4.11M

-166.19%-3.71M

47.75%-2.75M

-199.87%-2.28M

-335.22%-2.15M

-122.17%-1.39M

-1537.58%-5.27M

-277.61%-759.00K

---494.00K

---627.00K

---322.00K

---201.00K

--0.00

基本每股收益

54.00%1.91

11.70%1.77

189.61%2.74

143.57%1.33

3664.66%1.24

412.72%1.58

-67.13%0.95

143.70%0.54

101.87%0.03

124.72%0.31

347.13%2.88

-13.22%-1.25

11.45%-1.76

-32.24%-1.25

-66.02%-1.17

-49.31%-1.10

-167.42%-1.99

-79.20%-0.94

-43.69%-0.70

-98.27%-0.74

-141.81%-0.74

-70.48%-0.53

-97.69%-0.49

-0.93%-0.37

-7.90%-0.31

-13.03%-0.31

4.73%-0.25

-66.82%-0.37

-36.70%-0.29

-106.35%-0.27

49.65%-0.26

-152.55%-0.22

-266.65%-0.21

-83.42%-0.13

-1289.10%-0.52

-277.58%-0.09

---0.06

---0.07

---0.04

---0.02

--0.00

稀釋每股收益

53.27%1.83

11.66%1.70

192.67%2.66

145.30%1.29

3659.40%1.20

404.03%1.52

-67.48%0.91

142.16%0.53

101.81%0.03

124.14%0.30

339.86%2.79

-13.22%-1.25

11.45%-1.76

-32.24%-1.25

-66.02%-1.17

-49.31%-1.10

-167.42%-1.99

-79.20%-0.94

-43.69%-0.70

-98.27%-0.74

-141.81%-0.74

-70.48%-0.53

-97.69%-0.49

-0.93%-0.37

-7.90%-0.31

-13.03%-0.31

4.73%-0.25

-66.82%-0.37

-36.70%-0.29

-106.35%-0.27

49.65%-0.26

-152.55%-0.22

-266.65%-0.21

-83.42%-0.13

-1289.10%-0.52

-277.58%-0.09

---0.06

---0.07

---0.04

---0.02

--0.00

每股派息

--0.00

貨幣單位

--USD

審計意見

----

常見問題

如何在 TradingKey 上查看 Krystal Biotech Inc 的利潤表？



先看總營收，再依序查看營業成本、毛利、營業費用、營業利益、稅前淨利、淨利和每股盈餘（EPS）。營收反映公司的業務規模，而各項獲利和利潤率則體現公司能否有效地將營收轉化為獲利。

季度利潤表和年度利潤表有什麼區別？



季度利潤表反映公司在一個為期三個月的財務季度內的經營表現，年度損益表則彙總整個財年的業績。季度數據適合用於觀察近期發展勢頭和季節性變化，年度數據則更適合評估長期成長、獲利能力和業務週期。

利潤表頁面中的同比是什麼意思？



同比（即年增率，YoY）是指將某項財務指標與上年同期進行比較，例如將本季度營收與去年同一季度的營收進行對比。與去年同期比較的數據有助於投資者觀察成長趨勢，同時減少正常季節性變化對分析的影響。

分析 KRYS 股票時，哪些利潤表指標最重要？



重要的指標包括營收成長、毛利、毛利率、營業利益、營業利益率、淨利、每股盈餘、研發費用、銷售及管理費用以及所得稅費用。投資者通常會綜合分析這些指標，以判斷公司是否正在成長、有效控制成本並提升獲利能力。

Krystal Biotech Inc 財年末的營收是多少？



Krystal Biotech Inc 2025 財年營收為 389.13M，高於上一財年的 290.51M。

Krystal Biotech Inc 最近一個季度的營收是多少？



Krystal Biotech Inc 最近一個季度的營收為 116.36M，同比增長 31.95%。

Krystal Biotech Inc 全年的淨利潤是多少？



Krystal Biotech Inc 2025 財年淨利潤為 204.83M。

Krystal Biotech Inc 上一季度的淨利潤是多少？



Krystal Biotech Inc 最近一個季度的淨利潤為 55.93M。

Krystal Biotech Inc 年度營業利潤是多少？



Krystal Biotech Inc 2025 財年的營業利潤為 161.29M。

每股收益與利潤表有什麼關係？



每股收益（EPS）通常以淨利潤除以流通在外的股份數量計算，用於衡量公司平均每股創造的利潤。分析 EPS 時，還應結合股本變化、利潤率、現金流和估值指標進行綜合判斷。